Relation of replacement fibrosis to left ventricular diastolic function in patients with dilated cardiomyopathy

Journal of the American Society of Echocardiography

Volumn 24, Issue 3, 2011, Pages 333-338

  Malaty, Adham N ^a   Shah, Dipan J ^a   Abdelkarim, Ahmed R ^a   Nagueh, Sherif F ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Cardiomyopathy; Diastole; Doppler; Echocardiography

Indexed keywords

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; BREATH HOLDING; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FIBROSIS; HEART DISEASE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; MITRAL VALVE; NUCLEAR MAGNETIC RESONANCE IMAGING; SCAR; TISSUE DOPPLER IMAGING;

CARDIOMYOPATHY, DILATED; ELASTICITY IMAGING TECHNIQUES; ENDOMYOCARDIAL FIBROSIS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79951911648     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2010.12.017     Document Type: Article

References (22)

1. Vanoverschelde JL, Raphael DA, Robert AR, Cosyns JR. Left ventricular filling in dilated cardiomyopathy: relation to functional class and hemodynamics. J Am Coll Cardiol 1990;15:1288-95. (Pubitemid 20141106)
2. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009;22:107-33.
3. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 2008;10:35.
4. Moreo A, Ambrosio G, De Chiara B, Pu M, Tran T, Mauri F, et al. Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging 2009;2:437-43.
5. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
6. Kim RJ, Shah DJ, Judd RM. How we perform delayed enhancement imaging. J Cardiovasc Magn Reson 2003;5:505-14. (Pubitemid 36859434)
7. Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 2003;108:1945-53. (Pubitemid 37296539)
8. Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40:2156-64. (Pubitemid 36005903)
9. Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;43:2260-4. (Pubitemid 38757595)
10. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging 2002;18:539-42. (Pubitemid 34262671)
11. Zimmermann O, Grebe O, Merkle N, Nusser T, Kochs M, Bienek- Ziolkowski M, et al. Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy. Eur J Heart Fail 2006;8:162-6. (Pubitemid 43240850)
12. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003; 108:54-9. (Pubitemid 36859020)
13. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63. (Pubitemid 41821197)
14. Himura Y, Kumada T, Kambayashi M, Hayashida W, Ishikawa N, Nakamura Y, et al. Importance of left ventricular systolic function in the assessment of left ventricular diastolic function with Doppler transmitral flow velocity recording. J Am Coll Cardiol 1991;18:753-60.
15. Pinamonti B, Di Lenarda A, Sinagra G, Camerini F. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications: Heart Muscle Disease Study Group. J Am Coll Cardiol 1993;22:808-15. (Pubitemid 23256944)
16. Kasner M, Westermann D, Steendijk P, Gaub R, Wilkenshoff U, Weitmann K, et al. Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation 2007;11:637-47. (Pubitemid 47356348)
17. Wu Y, Cazorla O, Labeit D, Labeit S, Granzier H. Changes in titin and collagen underlie diastolic stiffness diversity of cardiac muscle. J Mol Cell Cardiol 2000;32:2151-62.
18. van Heerebeek L, Borbely A, Niessen HW, Bronzwaer JG, van der Velden J, Stienen GJ, et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 2006;113:1966-73.
19. LeWinter MM, Granzier H. Cardiac titin; a multifunctional giant. Circulation 2010;121:2137-45.
20. Nagueh SF, Sun H, Kopelen HA, Middleton KJ, Khoury DS. Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. J Am Coll Cardiol 2001;37:278-85. (Pubitemid 32051751)
21. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008;52:1574-80.
22. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010;122:138-44.